Viatris (VTRS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
2 Apr, 2026Executive summary
Annual meeting scheduled for May 15, 2026, at Hilton Naples, Naples, FL, with advance registration required for attendance.
Shareholders are encouraged to review proxy materials online and vote by May 14, 2026, or in person at the meeting.
Voting matters and shareholder proposals
Election of 13 director nominees to serve until the 2027 annual meeting.
Advisory vote on 2025 executive compensation for named executive officers.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
Provision for other business to be addressed as may properly come before the meeting.
Board of directors and corporate governance
Board recommends all 13 director nominees for election.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Viatris
- 2025 saw robust growth, pipeline advances, and strong governance, with key votes on directors, pay, and audit.VTRS
Proxy filing2 Apr 2026 - 2030 targets: 5–6% revenue CAGR, $3B+ free cash flow, and growth from innovation and portfolio shift.VTRS
Investor update20 Mar 2026 - 2025 revenues hit $14.3B, with $4.2B adjusted EBITDA and $650M in cost savings targeted.VTRS
Q4 202526 Feb 2026 - Q2 2024: $3.8B revenue, $326M net loss, $800M debt repaid, guidance raised.VTRS
Q2 20242 Feb 2026 - Transitioning to growth with new blockbuster assets and strong global execution.VTRS
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Major divestitures, acquisitions, and a strong pipeline set the stage for accelerated growth.VTRS
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Q3 2025 revenues flat, adjusted EBITDA and EPS down, $920M+ returned to shareholders, guidance raised.VTRS
Q3 202516 Jan 2026 - Q3 2024 saw solid operational growth, strong cash flow, and major debt reduction.VTRS
Q3 202415 Jan 2026 - Strong operational growth and pipeline progress support flexible capital allocation and innovation.VTRS
UBS Global Healthcare Conference14 Jan 2026